Although in this study involving in vivo CML mouse model, STAP-2 did not significantly affect the survival of CML mice; however, some of their phenotypes, such as the reduction in number of LSCs, were similar to STAP-1 deficient model (data not shown). The gene discussed is STAP1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.